# Expression Analysis of miRNA Profiles in Colorectal Cancer with a Bioinformatics Approach: An Emphasis on miR-4295, miR-4720-5p, miR-4773, and miR-6831-5p

**Authors:** Recep Eskin, Turkan Gurer, Alper Aytekin, Filiz Ozbas Gerceker

PMC · DOI: 10.3390/diagnostics16040614 · Diagnostics · 2026-02-19

## TL;DR

This study identifies specific microRNAs that are either increased or decreased in colorectal cancer tissues, suggesting their roles in cancer development.

## Contribution

The study identifies miR-4295 and miR-4720-5p as potentially oncogenic and miR-4773 and miR-6831-5p as tumor-suppressing in colorectal cancer.

## Key findings

- miR-4295 and miR-4720-5p were significantly upregulated in tumor tissues.
- miR-4773 and miR-6831-5p were significantly downregulated in tumor tissues.
- These miRNAs regulate genes in TGF-β, mTOR, ErbB, FoxO, and endocytosis pathways.

## Abstract

Background/Objectives: This study aimed to determine the potential roles of miR-4295, miR-4720-5p, miR-4773, miR-6831-5p, and miR-7161-5p in colorectal cancer by evaluating their expression levels in matched tumor and adjacent non-tumor tissues from 86 patients. Methods: A total of 172 samples were analyzed, and the associations between miRNA expression levels and clinicopathological characteristics were assessed, along with correlations among the miRNAs. Functional enrichment analyses, including GO and KEGG pathway evaluations, were performed using DIANA-mirPath v.3 to characterize biological processes and signaling pathways associated with the predicted target genes. Results: The results showed that miR-4295 and miR-4720-5p were significantly upregulated in tumor tissues, while miR-4773 and miR-6831-5p were significantly downregulated (p < 0.001). No significant difference in miR-7161-5p expression was observed between tumor and non-tumor tissues (p = 0.877). KEGG analysis indicated that miR-4295, miR-4720-5p, miR-4773, and miR-6831-5p regulate genes involved in the TGF-β, mTOR, ErbB, FoxO, and endocytosis signaling pathways. Conclusions: These findings suggest that miR-4295 and miR-4720-5p may have oncogenic functions, while miR-4773 and miR-6831-5p may have tumor-suppressing functions, and that this relationship may contribute to the development of colorectal cancer.

## Linked entities

- **Diseases:** colorectal cancer (MONDO:0005575)

## Full-text entities

- **Genes:** SMAD5 (SMAD family member 5) [NCBI Gene 4090] {aka DWFC, JV5-1, MADH5}, DEPDC1 (DEP domain containing 1) [NCBI Gene 55635] {aka DEP.8, DEPDC1-V2, DEPDC1A, SDP35}, MIR143 (microRNA 143) [NCBI Gene 406935] {aka MIRN143, mir-143}, EPS15 (epidermal growth factor receptor pathway substrate 15) [NCBI Gene 2060] {aka AF-1P, AF1P, MLLT5}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, ACVR1C (activin A receptor type 1C) [NCBI Gene 130399] {aka ACVRLK7, ALK7}, MIR133B (microRNA 133b) [NCBI Gene 442890] {aka MIRN133B, miRNA133B, mir-133b}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, MIR135B (microRNA 135b) [NCBI Gene 442891] {aka MIRN135B, mir-135b}, INHBA (inhibin subunit beta A) [NCBI Gene 3624] {aka EDF, FRP}, SMAD4 (SMAD family member 4) [NCBI Gene 4089] {aka DPC4, JIP, MADH4, MYHRS}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, BTG1 (BTG anti-proliferation factor 1) [NCBI Gene 694] {aka APRO2}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, MIR145 (microRNA 145) [NCBI Gene 406937] {aka MIRN145, miR-145, miRNA145}, MIR182 (microRNA 182) [NCBI Gene 406958] {aka MIRN182, miRNA182, mir-182}, CBLB (Cbl proto-oncogene B) [NCBI Gene 868] {aka ADMIO3, Cbl-b, Nbla00127, RNF56}, GPC5 (glypican 5) [NCBI Gene 2262], RNU6-1 (RNA, U6 small nuclear 1) [NCBI Gene 26827] {aka RNU6, RNU6A, RP103, U6, U6-1}, VTI1A (vesicle transport through interaction with t-SNAREs 1A) [NCBI Gene 143187] {aka MMDS3, MVti1, VTI1RP2, Vti1-rp2}, PTPN14 (protein tyrosine phosphatase non-receptor type 14) [NCBI Gene 5784] {aka CATLPH, PEZ, PTP36, PTPD2}, MARCHF8 (membrane associated ring-CH-type finger 8) [NCBI Gene 220972] {aka CMIR, MARCH-VIII, MARCH8, MIR, RNF178, c-MIR}, MIR494 (microRNA 494) [NCBI Gene 574452] {aka MIRN494, hsa-mir-494, mir-494}, KIF4A (kinesin family member 4A) [NCBI Gene 24137] {aka KIF4, KIF4G1, MRX100, TMDI, XLID100}, MIR6831 (microRNA 6831) [NCBI Gene 102465499] {aka hsa-mir-6831}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, SMAD1 (SMAD family member 1) [NCBI Gene 4086] {aka BSP-1, BSP1, JV4-1, JV41, MADH1, MADR1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, BUB1B (BUB1 mitotic checkpoint serine/threonine kinase B) [NCBI Gene 701] {aka BUB1beta, BUBR1, Bub1A, MAD3L, MVA1, SSK1}, SMAD2 (SMAD family member 2) [NCBI Gene 4087] {aka CHTD8, JV18, JV18-1, LDS6, MADH2, MADR2}, ACVR1 (activin A receptor type 1) [NCBI Gene 90] {aka ACTRI, ACVR1A, ACVRLK2, ALK2, FOP, SKR1}, ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase) [NCBI Gene 27] {aka ABLL, ARG}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, MIR4295 (microRNA 4295) [NCBI Gene 100422909], OIP5 (Opa interacting protein 5) [NCBI Gene 11339] {aka 5730547N13Rik, CT86, LINT-25, MIS18B, MIS18beta, hMIS18beta}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, MIR574 (microRNA 574) [NCBI Gene 693159] {aka MIR574-3p, MIRN574, hsa-mir-574, mir-574}, TGFBR1 (transforming growth factor beta receptor 1) [NCBI Gene 7046] {aka AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1}, WNT2B (Wnt family member 2B) [NCBI Gene 7482] {aka WNT13}, SMARCAD1 (SNF2 related chromatin remodeling ATPase with DExD box 1) [NCBI Gene 56916] {aka ADERM, BASNS, ETL1, HEL1, HPGDS-AS1, HRZ}, MIR7161 (microRNA 7161) [NCBI Gene 102465694] {aka hsa-mir-7161}, MIR4720 (microRNA 4720) [NCBI Gene 100616150], LRIG1 (leucine rich repeats and immunoglobulin like domains 1) [NCBI Gene 26018] {aka LIG-1, LIG1}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, CENPF (centromere protein F) [NCBI Gene 1063] {aka CENF, CILD31, PRO1779, STROMS, hcp-1}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}
- **Diseases:** diabetes (MESH:D003920), adenocarcinoma (MESH:D000230), cancer (MESH:D009369), pancreatic cancer (MESH:D010190), injury to (MESH:D014947), PDAC (MESH:D021441), osteosarcoma (MESH:D012516), glioma (MESH:D005910), HNSCC (MESH:D000077195), colon and/or rectum adenocarcinoma (MESH:D003110), genetic abnormalities (MESH:D030342), thyroid, gastric, kidney, and pancreatic cancers (MESH:D007680), colorectal adenomas (MESH:D000236), Colorectal carcinogenesis (MESH:D063646), autoimmune or inflammatory diseases (MESH:D001327), IMC (MESH:D013274), obesity (MESH:D009765), APC (MESH:D011125), infection (MESH:D007239), cardiovascular disease (MESH:D002318), mucinous adenocarcinoma (MESH:D002288), Colorectal Cancer (MESH:D015179), bladder, pancreatic, breast, prostate, and gastric cancers (MESH:C537243), GIST (MESH:D046152), metastasis (MESH:D009362), bladder cancer (MESH:D001749), ulcerative colitis (MESH:D003093), stage III-IV (MESH:D062706), hepatocellular carcinoma (MESH:D006528), lymph node metastases (MESH:D008207), breast cancer (MESH:D001943)
- **Chemicals:** alcohol (MESH:D000438), nitrogen compound (MESH:D017672)
- **Species:** Meleagris gallopavo (common turkey, species) [taxon 9103], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12939287/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939287/full.md

## References

71 references — full list in the complete paper: https://tomesphere.com/paper/PMC12939287/full.md

---
Source: https://tomesphere.com/paper/PMC12939287